This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ackermann, K. Articles by Pyerin, W. Search for Related Content PubMed PubMed Citation Articles by Ackermann, K. Articles by Pyerin, W.

Inhibition of Cyclic AMP-triggered Aromatase Gene Expression in Human Choriocarcinoma Cells by Antisense Oligodeoxynucleotide¹

Biochemical Cell Physiology, German Cancer Research Center, Im Neuenheimer Feld 280, D-69120 Heidelberg, Germany

Aromatase, an endomembrane-bound cytochrome P450, is the key enzyme of estrogen biosynthesis. Aromatase inhibitors, therefore, are clinically important tools in the treatment of estrogen-dependent tumor growth. To improve the specificity of these tools, inhibition at the nucleic acid level was examined. An antisense oligodeoxynucleotide complementary to the translation start region of human aromatase transcripts (antisense-arom) was synthesized and used to inhibit cyclic AMP-triggered aromatase gene expression in a human choriocarcinoma cell line (JEG-3), both as occurring in an autocrine fashion by secreted human chorionic gonadotropin or as induced by application of the membrane-permeating dibutyryl cyclic AMP. Significant inhibition was obtained in both cases, reaching 70% and 60%, respectively. In addition, the antisense-arom treatment led to accelerated mRNA degradation. The inhibition at the nucleic acid level was accompanied by a decrease of both the aromatase protein and microsomal aromatase activity. The data appear to indicate the antisense strategy to be a most promising approach for the development of a novel type of specific aromatase inhibitor.

¹ This work was supported by the Tumorzentrum Heidelberg/Mannheim and the Bundesministerium für Forschung und Technologie (Biomedizinischer Forschungsverbund).

² To whom requests for reprints should be addressed.

Received 4/ 8/94. Accepted 7/13/94.

This article has been cited by other articles:

				T. Nakanishi, J. Kohroki, S. Suzuki, J. Ishizaki, Y. Hiromori, S. Takasuga, N. Itoh, Y. Watanabe, N. Utoguchi, and K. Tanaka Trialkyltin Compounds Enhance Human CG Secretion and Aromatase Activity in Human Placental Choriocarcinoma Cells J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2830 - 2837. [Abstract] [Full Text] [PDF]

				I. H. Zwain and S. S. C. Yen Neurosteroidogenesis in Astrocytes, Oligodendrocytes, and Neurons of Cerebral Cortex of Rat Brain Endocrinology, August 1, 1999; 140(8): 3843 - 3852. [Abstract] [Full Text]

				I. H. Zwain and S. S. C. Yen Dehydroepiandrosterone: Biosynthesis and Metabolism in the Brain Endocrinology, February 1, 1999; 140(2): 880 - 887. [Abstract] [Full Text]